Hybrigenics Aktie
| 0,00EUR | -0,01EUR | -60,42% |
WKN DE: A0M9ZU / ISIN: FR0004153930
Personal
| 2018 | 2019 | 2021 | 2022 | 2024 | |
|---|---|---|---|---|---|
| Personal am Ende des Jahres | 0 | 0 | 0 | 0 | 0 |
| Umsatz pro Mitarbeiter in Mio. EUR | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
Bilanz (in Mio. EUR) - Aktiva
| 2018 | 2019 | 2021 | 2022 | 2024 | |
|---|---|---|---|---|---|
| Summe Umlaufvermögen | 0 | 3 | 4 | 5 | 1 |
| Summe Anlagevermögen | 0 | 2 | 9 | 10 | 5 |
| Summe Aktiva | 0 | 6 | 13 | 15 | 6 |
Bilanz (in Mio. EUR) - Passiva
| 2018 | 2019 | 2021 | 2022 | 2024 | |
|---|---|---|---|---|---|
| Summe Fremdkapital | 0 | 1 | 4 | 5 | 6 |
| Summe Eigenkapital | 0 | 5 | 9 | 10 | 1 |
| Summe Passiva | 0 | 6 | 13 | 15 | 6 |
Adresse
| 850, boulevard Sébastien Brant, 67400 Illkirch-Graffenstaden | |
| Telefon | +33 (1) 72-56-94-99 |
| Internet | http://www.aton-group.com |
Management
|
Ayikoélé Léone Atayi
Chairman & Chief Executive Officer |
|
Elie Fraenckel
Independent Director |
|
Enrico Jose Adolfo Bastianelli
Independent Director |
|
Hadrien Lanvin
Independent Director |
|
Pierre Eftekhari
Director |
|
Virginie Miath
Independent Director |